The retrospective study, conducted in centers across Germany, found that when colorectal cancer was detected during a screening colonoscopy, patients lived nearly 2 years longer than if it was detected during a diagnostic colonoscopy.
A long-term, retrospective, multicenter study in Germany followed 60 patients diagnosed with colorectal cancer (CRC) during screening colonoscopy and 252 patients during diagnostic colonoscopy in 2002, 2003, and 2004. The patients, 55 years of age or older, were followed for about a decade till 2013, with survival as the primary outcome being analyzed.
The study, published in Gastrointestinal Endoscopy, found that patients with CRC diagnosed during screening colonoscopy lived significantly longer (20.2 months longer) when compared with patients with CRC diagnosed during diagnostic colonoscopy. About 55% of the patients with diagnostic colonoscopy, and about 77% of the screening colonoscopy patients, survived beyond the time period of the study.
Read more on ScienceDaily
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More